FDA Official Warns Other Drug Makers Not to Copy Sarepta

Oct 21, 2016, 10:34 by Michael Croft

STAT | An FDA official said this week that Sarepta's approach in winning approval for its DMD drug should not be copied by other drug firms.

October 21, 2016 | An FDA official said this week that Sarepta's approach in winning approval for its DMD drug should not be copied by other drug firms. STAT